Dupont Capital Management Corp Innoviva, Inc. Transaction History

Dupont Capital Management Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$14.32 - $19.88 $240,289 - $333,586	-16,780 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$15.39 - $20.25 $22,854 - $30,071	-1,485 Reduced 8.13%	16,780 $325,000
Q4 2021 Jan 31, 2022	SELL	$15.91 - $18.72 $389,540 - $458,340	-24,484 Reduced 57.27%	18,265 $315,000
Q3 2021 Nov 03, 2021	SELL	$13.06 - $17.24 $78,908 - $104,164	-6,042 Reduced 12.38%	42,749 $714,000
Q2 2021 Jul 30, 2021	SELL	$11.45 - $13.96 $101,905 - $124,244	-8,900 Reduced 15.43%	48,791 $654,000
Q1 2021 Apr 29, 2021	SELL	$11.06 - $12.87 $130,861 - $152,277	-11,832 Reduced 17.02%	57,691 $689,000
Q4 2020 Jan 28, 2021	SELL	$9.33 - $12.48 $48,413 - $64,758	-5,189 Reduced 6.95%	69,523 $861,000
Q3 2020 Oct 29, 2020	SELL	$10.33 - $14.49 $51,691 - $72,507	-5,004 Reduced 6.28%	74,712 $781,000
Q2 2020 Jul 24, 2020	SELL	$11.49 - $15.26 $81,774 - $108,605	-7,117 Reduced 8.2%	79,716 $1.11 Million
Q1 2020 Apr 29, 2020	SELL	$8.11 - $15.23 $135,388 - $254,249	-16,694 Reduced 16.13%	86,833 $1.02 Million
Q3 2019 Oct 28, 2019	SELL	$10.05 - $14.55 $111,544 - $161,490	-11,099 Reduced 9.68%	103,527 $1.09 Million
Q2 2018 Jul 30, 2018	BUY	$13.44 - $17.59 $1.54 Million - $2.02 Million	114,626 New	114,626 $1.58 Million
Q1 2018 May 02, 2018	SELL	$13.8 - $16.99 $598,078 - $736,329	-43,339 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$11.73 - $14.75 $448,179 - $563,568	-38,208 Reduced 46.85%	43,339 $615,000
Q3 2017 Oct 31, 2017	BUY	$12.06 - $14.12 $983,456 - $1.15 Million	81,547	81,547 $1.15 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.